Literature DB >> 24025154

Regulatory role of miRNAs in polyamine gene expression in the prefrontal cortex of depressed suicide completers.

Juan Pablo Lopez1, Laura M Fiori, Jeffrey A Gross, Benoit Labonte, Volodymyr Yerko, Naguib Mechawar, Gustavo Turecki.   

Abstract

MicroRNAs (miRNAs) are small, non-coding RNA molecules that play an important role in the post-transcriptional regulation of mRNA. These molecules have been the subject of growing interest as they are believed to control the regulation of a large number of genes, including those expressed in the brain. Evidence suggests that miRNAs could be involved in the pathogenesis of neuropsychiatric disorders. Alterations in metabolic enzymes of the polyamine system have been reported to play a role in predisposition to suicidal behaviour. We have previously shown the expression of the polyamine genes SAT1 and SMOX to be down-regulated in the brains of suicide completers. In this study, we hypothesized that the dysregulation of these genes in depressed suicide completers could be influenced by miRNA post-transcriptional regulation. Using a stringent target prediction analysis, we identified several miRNAs that target the 3'UTR of SAT1 and SMOX. We profiled the expression of 10 miRNAs in the prefrontal cortex (BA44) of suicide completers (N = 15) and controls (N = 16) using qRT-PCR. We found that several miRNAs showed significant up-regulation in the prefrontal cortex of suicide completers compared to psychiatric healthy controls. Furthermore, we demonstrated a significant correlation between these miRNAs and the expression levels of both SAT1 and SMOX. Our results suggest a relationship between miRNAs and polyamine gene expression in the suicide brain, and postulate a mechanism for SAT1 and SMOX down-regulation by post-transcriptional activity of miRNAs.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24025154     DOI: 10.1017/S1461145713000941

Source DB:  PubMed          Journal:  Int J Neuropsychopharmacol        ISSN: 1461-1457            Impact factor:   5.176


  38 in total

Review 1.  Heterogeneity and individuality: microRNAs in mental disorders.

Authors:  Leif G Hommers; Katharina Domschke; Jürgen Deckert
Journal:  J Neural Transm (Vienna)       Date:  2014-11-14       Impact factor: 3.575

Review 2.  The molecular bases of the suicidal brain.

Authors:  Gustavo Turecki
Journal:  Nat Rev Neurosci       Date:  2014-10-30       Impact factor: 34.870

Review 3.  Neuropathology of suicide: recent findings and future directions.

Authors:  P-E Lutz; N Mechawar; G Turecki
Journal:  Mol Psychiatry       Date:  2017-07-11       Impact factor: 15.992

Review 4.  A Slice of the Suicidal Brain: What Have Postmortem Molecular Studies Taught Us?

Authors:  Daniel Almeida; Gustavo Turecki
Journal:  Curr Psychiatry Rep       Date:  2016-11       Impact factor: 5.285

Review 5.  Pathogenetic and therapeutic applications of microRNAs in major depressive disorder.

Authors:  Yogesh Dwivedi
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2015-02-14       Impact factor: 5.067

Review 6.  Progress in Elucidating Biomarkers of Antidepressant Pharmacological Treatment Response: A Systematic Review and Meta-analysis of the Last 15 Years.

Authors:  G Voegeli; M L Cléry-Melin; N Ramoz; P Gorwood
Journal:  Drugs       Date:  2017-12       Impact factor: 9.546

Review 7.  MicroRNAs in depression and suicide: Recent insights and future perspectives.

Authors:  Yogesh Dwivedi
Journal:  J Affect Disord       Date:  2018-07-24       Impact factor: 4.839

8.  Whole-gene sequencing investigation of SAT1 in attempted suicide.

Authors:  Eric T Monson; Kelly de Klerk; Sophia C Gaynor; Alex H Wagner; Marie E Breen; Meredith Parsons; Thomas L Casavant; Peter P Zandi; James B Potash; Virginia L Willour
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2016-05-27       Impact factor: 3.568

9.  Overlapping MicroRNA Expression in Saliva and Cerebrospinal Fluid Accurately Identifies Pediatric Traumatic Brain Injury.

Authors:  Steven D Hicks; Jeremiah Johnson; Molly C Carney; Harry Bramley; Robert P Olympia; Andrea C Loeffert; Neal J Thomas
Journal:  J Neurotrauma       Date:  2017-10-27       Impact factor: 5.269

Review 10.  Diagnostic and therapeutic potential of microRNAs in neuropsychiatric disorders: Past, present, and future.

Authors:  Begum Alural; Sermin Genc; Stephen J Haggarty
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2016-04-09       Impact factor: 5.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.